Location: NEW BRUNSWICK, NJ
CIK: 0000200406 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Mar 18, 2026
Total Value ($000): $555,048 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma, Inc. | 53,732 | $703 | 0.1% | $18.62 | 0.0% | COM NEW | 929033207 |
| ACET | Adicet Bio, Inc. | 22,779 | $192 | 0.0% | $11.05 | 0.0% | COM NEW | 007002207 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. | 247,598 | $8,540 | 1.5% | $64.75 | -24.3% | — | 04280A100 |
| — | Vor Biopharma, Inc. | 53,732 | $2,618 | 0.5% | $15.68 | — | — | 929033108 |
| — | Adicet Bio, Inc. | 364,472 | $295 | 0.1% | $7.84 | — | — | 007002108 |
| — | BiomX Inc. | 96,866 | $51 | 0.0% | $3.06 | — | — | 09090D103 |
| — | Senseonics Holdings, Inc. | 54,621 | $24 | 0.0% | $3.39 | — | — | 81727U105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CVRX | CVRx, Inc. | 4,024,861 (-1.9%) | $28,577 (-13.7%) | 5.1% | $19.85 | -54.0% | COM | 126638105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc. | 2,449,183 | $213,912 | 38.5% | $42.63 | +92.0% | COM | 74366E102 |
| NBTX | Nanobiotix S.A. | 5,623,816 | $130,023 | 23.4% | $7.53 | — | SPONSORED ADS | 63009J107 |
| LEGN | Legend Biotech Corporation | 814,586 | $17,709 | 3.2% | $50.56 | — | SPONSORED ADS | 52490G102 |
| XNCR | Xencor, Inc. | 748,062 | $11,453 | 2.1% | $37.91 | -60.6% | COM | 98401F105 |
| MGTX | MeiraGTx Holdings plc | 6,641,064 | $52,796 | 9.5% | $9.84 | -15.5% | COM | G59665102 |
| PRCT | Procept BioRobotics Corporation | 357,939 | $11,261 | 2.0% | $38.38 | -13.6% | COM | 74276L105 |
| RAPP | Rapport Therapeutics, Inc. | 1,784,517 | $54,142 | 9.8% | $23.15 | +19.5% | COM | 75383L102 |
| FATE | Fate Therapeutics, Inc. | 3,379,064 | $3,320 | 0.6% | $78.44 | -98.5% | COM | 31189P102 |
| LYEL | Lyell Immunopharma, Inc. | 54,887 | $1,689 | 0.3% | $11.42 | +96.0% | COM NEW | 55083R203 |
| — | Rallybio Corporation | 3,636,363 | $2,495 | 0.4% | $1.34 | — | COM | 75120L100 |
| CTNM | Contineum Therapeutics Inc. | 1,979,173 | $22,622 | 4.1% | $16.10 | -29.2% | CL A | 21217B100 |
| NNOX | Nano-X Imaging Ltd. | 158,852 | $445 | 0.1% | $15.61 | -77.0% | ORD SHS | M70700105 |
| NMRA | Neumora Therapeutics, Inc. | 1,849,445 | $3,311 | 0.6% | $12.57 | -82.6% | COM | 640979100 |
| LAB | Standard BioTools, Inc. | 311,967 | $399 | 0.1% | $2.41 | -44.4% | COM | 34385P108 |